Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Hongbao Cao

Hongbao Cao

Senior Bioinformatics Scientist for Elsevier Biology Solutions

About the author: Dr. Hongbao Cao is a Senior Bioinformatics Scientist for Elsevier Biology Solution based in Washington DC, USA. In his current role, Dr. Cao is focused on understanding the ongoing challenges of researchers in the field of biology, with the overall aim of developing information solutions that help them effectively innovate. Dr. Cao earned his BME Bachelor's and Master's degree in Tianjin University, Tianjin, China, and his BME Ph.D degree at Louisiana Tech University, USA. Before joining Elsevier, Dr. Cao worked at NIMH/NIH as a Senior Scientist.

Posts by Hongbao Cao

Hydroxychloroquine and the Coronavirus: Connecting the Dots Through the Biology Knowledge Graph

Posted on April 16th, 2020 in COVID-19

It would be hard to miss the current interest in finding effective treatment for COVID-19. In this regard, the combination of hydroxychloroquine (HCQ) with azithromycin is getting a great deal of attention. HCQ, sold under the brand name Plaquenil, is a well-known anti-malarial drug, while azithromycin is a common antibiotic that is usually used for the treatment of strep throat (the widely used Zithromax, Z-Pak).